Atlas Trials

Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Clinical trial NCT04348006 · WITHDRAWN

Trial details

NCT number
NCT04348006
Sponsor
Al-Rasheed University College
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Newly Diagnosed Multiple Myeloma
Start date
2020-03-01
Primary completion
2021-07-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.